Related Experiment Video
Updated: Apr 17, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.9K
Revolution in hepatitis C antiviral therapy
Matthew D Sadler1, Samuel S Lee2
1Division of Gastroenterology and Hepatology, University of Calgary Liver Unit, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1.
British Medical Bulletin
|February 15, 2015
Summary
New direct-acting antivirals (DAA) are transforming hepatitis C virus (HCV) treatment, offering superior efficacy with fewer side effects. The ideal interferon-free regimen is still under investigation, especially for challenging cases like HCV genotype 3.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) management is undergoing rapid evolution.
- Direct-acting antivirals (DAAs) represent a significant advancement in HCV therapy.
Purpose of the Study:
- To review the current landscape of DAAs in HCV treatment.
- To identify emerging trends, challenges, and areas for future research in HCV therapy.
Main Methods:
- Systematic review of peer-reviewed literature on DAAs.
- Inclusion of data from recent international congress presentations (abstracts).
Main Results:
- New DAAs demonstrate high efficacy and improved safety profiles compared to older treatments.
- Shorter, interferon-free regimens are becoming the standard of care for HCV.
- Variable global access to DAAs and ongoing research into optimal treatment strategies exist.
Conclusions:
- Combination DAA therapies are under investigation to determine the ideal interferon-free regimen.
- HCV genotype 3 remains a treatment challenge, necessitating more effective regimens.
- Further research is needed for specific patient subgroups, including those with decompensated cirrhosis.
Keywords:
asunaprevirboceprevirdaclatasvirdirect-acting antiviralshepatitis C virusledipasvirpeg-interferonribavirinsimeprevirsofosbuvirtelaprevirMore Related Videos
Related Concept Videos
01:25Hepatitis
63
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
01:10Retrovirus Life Cycles
50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
01:30Inhibitors of Viral Protein Synthesis
37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.4K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.4K
01:17Hepatic Drug Excretion: Enterohepatic Cycling
3.4K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.4K
01:09Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
742
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
742